… Therefore, retesting should be considered before B-cell or antibody-targeted therapies (plasma
exchange, immunosuppressive drugs) are instituted and in seronegative patients who …

The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research
and clinical practice. Scientific advances in the past 7 years suggest that they might no …

… B. Banwell serves as a senior editor for Multiple Sclerosis and Related Disorders and on
the editorial board of Neurology®. Dr Banwell serves on a steering committee for Biogen Idec, …

New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis
of multiple sclerosis. The use of imaging for demonstration of dissemination of central …

Background: The CNS inflammatory demyelinating disorders of childhood include both self-limited
and lifelong conditions, which can be indistinguishable at the time of initial …

Background: There has been tremendous growth in research in pediatric multiple sclerosis (MS)
and immune mediated central nervous system demyelinating disorders since …

… Brenda Banwell … T- and B-cell responses to myelin oligodendrocyte glycoprotein in
experimental autoimmune encephalomyelitis and multiple sclerosis. … Banwell B …

Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases
that could better explain the clinical and paraclinical findings. A systematic process for …

… (B) Clinical features at onset from the combined UK, French, Sri Lankan, Dutch, and
Australian cohorts, and divided into paediatric and adult populations from studies where the …

The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple
Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple …